Search the Newsreel

Boston Pizza Royalties Income Fund Revenue Breakdown – TSX:BPF.UN

Boston Scientific Corp (BSX) Financial Health: Profitability & Balance Sheet Analysis

Boston Scientific Corp (BSX) currently holds a strong financial score of 8.02, ranking 46th out of 200 in the Healthcare Equipment & Supplies industry. The company exhibits stable financial health and high operating efficiency, with recent quarterly revenue increasing by 11.58% year-over-year and net …

Boston Beer Company (SAM) Reported Weaker Q2 Results, Is The Stock Still Below Fair Value?

Boston Omaha Corporation Revenue Breakdown – NYSE:BOC

Boston Scientific percutaneous catheters focus of FDA safety alert

[Nurse opening sterile package containing iv catheter in hospital setting] Carmen Ruiz alonso/iStock via Getty Images * The US FDA is recommending that certain lots of Boston Scientific's (BSX [https://seekingalpha.com/symbol/BSX]) ENROUTE Transcarotid Neuroprotection System percutaneous catheters be avoided following reports of arterial sheath tip …

Boston Scientific Corp (BSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed breakdown of Boston Scientific Corp's (BSX) revenue by business segment and geographical region. It shows that Interventional Cardiology Therapies and Electrophysiology are major contributors to its revenue, with a significant portion of its sales originating from the United States. …

Boston Beer Q2 Earnings Miss Estimates on Higher Marketing Costs

Boston Beer reported lower-than-expected Q2 2026 revenues and earnings, with adjusted EPS of $3.65 missing estimates and net revenues declining 3.3%. The company faced weaker volumes for key brands and increased advertising and promotional expenses, impacting profitability. Despite these challenges, Boston Beer maintained liquidity, …

Boston Scientific Corporation Revenue Breakdown – NYSE:BSX

Boston Scientific (BSX) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

The upcoming report from Boston Scientific (BSX) is expected to reveal quarterly earnings of $0.83 per share, indicating an increase of 10.7% compared to the year-ago period. Analysts forecast revenues of $5.39 billion, representing an increase of 6.5% year over year. Over the last …

BSX|Boston Scientific Corp|Price:43.590|Chg%:+0.620

Boston Scientific Corp (BSX) is trading at $43.780, up 0.46%, with a market cap of $65.07B. The company exhibits strong fundamentals including high revenue and profit growth, and is considered fairly valued in the Healthcare Equipment & Supplies industry. While institutional ownership is very …

Boston Scientific stock trades firm as cardiovascular revenue grows and TAVR momentum supports earni

Boston Scientific's stock stability is driven by strong cardiovascular and MedSurg performance, with Q1 2025 net sales increasing by approximately 10% to $3.86 billion. The growth is particularly fueled by its Cardiovascular segment, which saw a 12% increase, largely due to demand for its …

SAM Q2 Deep Dive: SunCruiser Gains, Twisted Tea Headwinds Shape Boston Beer’s Outlook

Royal Bank Of Canada Issues Pessimistic Forecast for Boston Beer (NYSE:SAM) Stock Price

Boston Beer’s (NYSE:SAM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Boston Beer reports Q2 revenue $568.3M, gross margin 50.4% and GAAP EPS $4.96

Boston Beer (SAM) announced its Q2 2026 financial results, reporting net revenue of $568.3 million, a 3.3% decrease year-over-year, and a gross margin of 50.4%. GAAP diluted EPS was $4.96, including a significant one-time benefit from supplier litigation, while non-GAAP diluted EPS stood at …

BOSC Secures $990,000 Order in Supply Chain Division

BOSC's Supply Chain Division has secured a $990,000 purchase agreement for electromechanical connectors from a current U.S. client, with deliveries expected between Q4 2026 and Q1 2027. The company's P/E ratio of 9.61 suggests it might be undervalued, and it holds a GF Score™ …

B.O.S. Better Online Solutions (BOSC) IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 summary

B.O.S. Better Online Solutions (BOSC) presented at the IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, highlighting its strategic focus on integrating supply chain technologies for defense and retail across its robotics, RFID, and supply chain divisions. The company reported 21 consecutive profitable …

BOS Secures $990,000 Order from a U.S. Customer

BOS Better Online Solutions Ltd. (NASDAQ: BOSC) announced its Supply Chain Division secured a $990,000 purchase order from an existing U.S. customer for electromechanical connectors. The delivery is anticipated in late 2026 and early 2027. The company highlighted significant international sales growth, particularly in …

Same Industry, Less Money: What Boston Scientific and ResMed Offers That Abbott Laboratories Does Not

This article analyzes the valuations of Abbott Laboratories (ABT), Boston Scientific (BSX), and ResMed (RMD) within the medical device industry. It highlights that ABT trades at a premium despite slower growth compared to BSX, which offers faster growth at a lower price. The author …

Boston Scientific (BSX) Enrolls First Patients In Global Faraflex AFib Trial

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Boston Scientific (NYSE:BSX) has enrolled the first patients in the global FARADIGM trial. The study evaluates the Faraflex pulsed field ablation device for the treatment …

Boston Beer (NYSE:SAM) Posts Earnings Results, Misses Expectations By $1.18 EPS

BOS U.S. and India sales grow 165% to $8.5M in 2026

BOS Better Online Solutions (NASDAQ:BOSC) announced securing a $990,000 purchase order from an existing U.S. customer for electromechanical connectors, with delivery expected in Q4 2026 and Q1 2027. The company also reported a significant 165% year-to-date increase in U.S. and India sales to $8.5 …

Boston Beer (SAM) Q2 Earnings and Revenues Miss Estimates

Boston Beer Company (SAM) Releases Q2 2026 Earnings: Revenue Miss and Profit Decline | SAM Stock News

Boston Beer’s shipments fell 4.5% while gross margin rose to 50.4%

Boston Beer Q2 Earnings Call Highlights

B.O.S. Better Online Solutions (BOSC) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live quotes and charts for B.O.S. Better Online Solutions (BOSC) stock on NASDAQ, showing a current price of $4.34 with a decline of 3.13%. It also includes disclaimers about the risks of trading and refers to studies indicating that most day …

Millennium Group (NYSE: SAM) cuts Boston Beer stake to 4.9% of Class A

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have reported a beneficial ownership of 411,413 shares of The Boston Beer Company, Inc. Class A Common Stock, which constitutes 4.9% of the class. The group previously held more than 5% of the …

Boston Scientific stock trades steady as recent earnings and cardiovascular portfolio shape investor

Boston Scientific's stock performance is analyzed based on its recent earnings trajectory and its robust cardiovascular device portfolio. The company demonstrates strong organic revenue growth in its core segments and improved profitability, leading to significant EPS growth. Its strategy involves continuous innovation, strategic acquisitions, …

U.S. Information Request

NEWMARKET, Ontario, July 22, 2026 (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that AirBoss Rubber Compounding (NC), LLC (“AirBoss NC”), a wholly-owned subsidiary of the Company, has received a request for information from the U.S. …

Boston Scientific, Stryker Settle Surgical Device Patent Dispute

Boston Scientific Corp. and Stryker Corporation have reached an agreement in principle to settle their patent dispute over a surgical device used to treat chronic lower back pain. This settlement comes shortly after Boston Scientific failed to block sales of Stryker’s competing product. The …

Boston Scientific (BSX) Stock Still Looks Undervalued Following Its 58% Slump

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Boston Scientific stock has had a tough run over the past year, yet the valuation checks still lean supportive, setting up a clear tension …

Boston Scientific stock trades steadily as device maker grows revenue and prepares for next earnings

Boston Scientific (BSX) stock is trading steadily due to consistent share-price performance and revenue growth. The company, a major medical device manufacturer, is expanding its cardiovascular and neuromodulation portfolio and has reported strong double-digit revenue growth in recent periods, driven by product launches and …

Boston Scientific (BSX) Recalls Put Focus On Whether The Stock Still Looks Undervalued

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Recall driven attention on Boston Scientific stock Boston Scientific (BSX) is back in focus after a series of voluntary recalls for its CRE and …

What To Expect From Boston Beer’s (SAM) Q2 Earnings

Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock?

Boston Scientific BSX is slated to report second-quarter 2026 results on July 29, before the market opens. The Zacks Consensus Estimate for the company's second-quarter earnings per share (EPS) suggests 10.7% year-over-year growth to 83 cents. The estimate has remained constant in the past …